Cargando…
A controlled trial of value-based insurance design – The MHealthy: Focus on Diabetes (FOD) trial
BACKGROUND: Diabetes affects over 20 million Americans, resulting in substantial morbidity, mortality, and costs. While medications are the cornerstone of secondary prevention, many evidence-based therapies are underutilized, and patients often cite out-of-pocket costs as the reason. Value-based ins...
Autores principales: | Spaulding, Alicen, Fendrick, A Mark, Herman, William H, Stevenson, James G, Smith, Dean G, Chernew, Michael E, Parsons, Dawn M, Bruhnsen, Keith, Rosen, Allison B |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2673203/ https://www.ncbi.nlm.nih.gov/pubmed/19351413 http://dx.doi.org/10.1186/1748-5908-4-19 |
Ejemplares similares
-
Value-Based Insurance Design: A “Clinically Sensitive, Fiscally Responsible” Approach to Mitigate The Adverse Clinical Effects of High-Deductible Consumer-Directed Health Plans
por: Fendrick, A. Mark, et al.
Publicado: (2007) -
Connexins and Pannexins—Similarities and Differences According to the FOD-M Model
por: Roterman, Irena, et al.
Publicado: (2022) -
A Clutter-Analysis-Based STAP for Moving FOD Detection on Runways
por: Yang, Xiaoqi, et al.
Publicado: (2019) -
Dependence of Protein Structure on Environment: FOD Model Applied to Membrane Proteins
por: Roterman, Irena, et al.
Publicado: (2021) -
New insights into disordered proteins and regions according to the FOD-M model
por: Roterman, Irena, et al.
Publicado: (2022)